MARVEL BIOSCIENCES CORP (MRVL.CA) Stock Income Statement
TSX-V:MRVL - TSX Venture Exchange - CA57384M1077 - Common Stock - Currency: CAD
| TTM (2025-1-31) | 2024 (2024-7-31) | 2023 (2023-7-31) | 2022 (2022-7-31) | 2021 (2021-7-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | N/A | 0.00 | 0.00 | |||
| Operating Expenses | 1.36M | 1.27M | 2.38M | 2.55M | 3.16M | |||
| Research and Development | 343.20K | 302.00K | 887.50K | 1.38M | N/A | |||
| Selling, General, and Administrative Expenses | 1.01M | 969.90K | 1.49M | 1.17M | 3.16M | |||
| Operating Income | -1.36M | -1.27M | -2.38M | -2.55M | -3.16M | |||
| Interest Income/Expense | -457.40K | -378.20K | -39.40K | -4.30K | 10.00K | |||
| Other Income/Expense | N/A | N/A | 126.20K | 0.00 | 120.00K | |||
| Income Before Taxes | -1.66M | -1.65M | -2.29M | -2.55M | -3.04M | |||
| Net Income | -1.66M | -1.65M | -2.29M | -2.55M | -3.04M | |||
| EBITDA | N/A | N/A | N/A | -2.55M | N/A | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.04 | -0.04 | -0.06 | -0.08 | -0.17 | |||
| Statistics | ||||||||
All data in CAD